Cargando…
Bromocriptine Use in Peripartum Cardiomyopathy: Review of Cases
Objective This study is to review published cases of peripartum cardiomyopathy (PPCM) treated with bromocriptine and outline pros and cons of the treatment strategy. Data Sources Data were collected from PubMed/MedLine, ClinicalTrials.gov; the years 2007 to 2018 were searched for English-language...
Autores principales: | Simon, Rebecca, Yang, Sophia, Hameed, Afshan B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Thieme Medical Publishers
2018
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249133/ https://www.ncbi.nlm.nih.gov/pubmed/30473907 http://dx.doi.org/10.1055/s-0038-1675832 |
Ejemplares similares
-
A Systematic Review of the Utility of Bromocriptine in Acute Peripartum Cardiomyopathy
por: Badianyama, Marheb, et al.
Publicado: (2021) -
Bromocriptine as a new therapeutic agent for peripartum cardiomyopathy
por: Chopra, Sandeep, et al.
Publicado: (2012) -
Bromocriptine treatment in patients with peripartum cardiomyopathy and right ventricular dysfunction
por: Haghikia, Arash, et al.
Publicado: (2018) -
Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study
por: Hilfiker-Kleiner, Denise, et al.
Publicado: (2017) -
Bromocriptine use for sudden peripartum cardiomyopathy in a patient with preeclampsia: a case report
por: Hakata, Saya, et al.
Publicado: (2019)